Research Articles | Page 8 | Aplastic Anemia & MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Eculizumab treatment of paroxysmal nocturnal hemoglobinuria presenting as moyamoya syndrome in a 9-year-old male. Jan 2012 Pediatr Blood Cancer paroxysmal nocturnal hemoglobinuria (PNH)
Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia Feb 2014 Pediatr Blood Cancer aplastic anemia
Myelodysplastic Syndromes Treatment (PDQ®): Patient Version Oct 2015 PDQ Cancer Information Summaries [Internet] myelodysplastic syndromes (MDS)
Dysregulated miR34a/diacylglycerol kinase ζ interaction enhances T-cell activation in acquired aplastic anemia Dec 2016 Oncotarget aplastic anemia
Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapy Feb 2017 Oncotarget myelodysplastic syndromes (MDS)
Outcome of patients treated for myelodysplastic syndromes with 5q deletion after failure of lenalidomide therapy. Jun 2017 Oncotarget myelodysplastic syndromes (MDS)
Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS) Aug 2016 Oncotarget myelodysplastic syndromes (MDS)
Molecular Testing in Myelodysplastic Syndromes for the Practicing Oncologist: Will the Progress Fulfill the Promise? Jul 2015 Oncologist myelodysplastic syndromes (MDS)
The Challenging World of Cytopenias: Distinguishing Myelodysplastic Syndromes From Other Disorders of Marrow Failure Jun 2014 Oncologist myelodysplastic syndromes (MDS)
The Incidence and Health Care Resource Burden of the Myelodysplastic Syndromes in Patients in Whom First-Line Hypomethylating Agents Fail Mar 2017 Oncologist myelodysplastic syndromes (MDS)